Wright medical group n.v. (WMGI)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jul'18Apr'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Jan'12Sep'11Jun'11Mar'11
Operating activities:
Net loss

-92,530

-114,225

-131,970

-130,706

-180,592

-169,505

-106,604

-195,949

-169,413

-202,598

-276,601

-254,876

-443,080

-432,373

-493,280

-481,996

-296,945

-298,701

-201,389

-107,849

-73,982

-29,471

-31,705

-32,676

-34,765

-36,426

-30,530

-35,919

-28,466

-21,744

-18,922

-8,878

-6,663

-30,456

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,623

40,357

39,047

37,558

36,566

35,637

33,666

32,076

30,232

28,467

28,563

28,001

28,107

0

0

0

Non-cash foreign currency loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,087

-926

-1,082

-1,577

-1,829

-801

86

171

495

306

-72

578

-298

0

0

0

Depreciation

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

-

-

-

-

-

-

0

0

0

-

56,840

56,589

57,006

56,782

54,581

46,100

37,423

29,481

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Share-based compensation expense

32,276

32,567

31,263

30,285

28,723

26,120

23,598

21,786

20,457

19,393

18,646

16,729

15,053

14,416

27,159

25,656

25,944

24,964

10,538

10,861

10,258

9,701

10,416

9,752

8,447

8,300

6,475

6,503

6,519

6,830

6,914

7,033

7,196

6,547

0

0

0

Amortization of intangible assets

32,458

31,921

31,456

29,029

27,176

26,730

25,853

27,150

28,140

28,396

29,008

29,294

29,950

29,180

30,927

26,025

20,935

16,922

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of deferred financing costs and debt discount

54,604

54,461

54,566

54,592

54,875

54,630

53,647

52,722

51,497

50,379

49,184

48,004

44,727

40,487

36,101

32,170

34,247

27,600

20,385

12,977

1,859

775

778

757

893

969

0

0

0

-

-

-

-

2,040

0

0

0

Deferred income taxes

-2,099

-2,464

-3,424

-4,250

-4,382

-4,543

-14,708

-14,597

-14,571

-13,791

28,058

23,057

20,598

20,583

-6,449

-114

3,070

3,087

-2,637

-5,456

-6,720

-7,893

-3,617

-1,197

1,183

3,566

-2,430

-1,726

-2,595

-4,506

-2,773

-5,906

-4,249

-11,619

0

0

0

Inventory Write-down

11,193

13,126

13,699

15,904

19,399

20,913

22,759

22,577

20,541

19,171

19,645

19,187

21,682

22,046

19,463

20,533

16,438

14,218

13,970

9,918

10,041

11,433

10,454

9,946

9,273

8,447

11,640

10,294

9,041

8,171

4,095

4,586

4,890

4,996

0

0

0

Inventory Step Up Amortization Expense

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

InventoryStepUpAmortizationExpense

705

1,057

1,409

1,056

704

352

0

0

0

-

-

-

-

41,503

45,633

34,202

22,688

11,356

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash adjustment to derivative fair values

-25,663

-10,962

706

-451

33,244

35,934

33,709

33,740

-3,468

-4,797

-5,976

-8,964

-21,267

-28,273

-24,483

-25,948

-9,751

-10,045

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss on exchange of cash convertible notes

0

14,274

14,274

14,274

54,209

39,935

0

0

0

-

-

-

-

-

-

-

-

25,101

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Mark-to-market adjustment for CVRs

0

-420

2,804

6,140

3,644

140

-4,485

-3,316

-4,764

5,320

6,441

4,197

9,524

8,688

8,687

21,019

11,207

-7,571

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-29,475

0

0

0

Acquired inventory step up

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

577

1,040

2,652

4,415

5,908

0

0

0

-

-

-

-

-

-

-

-

Other

-7,319

-7,322

6,096

6,536

2,317

1,617

91

-707

-949

-1,385

-3,024

-3,843

-3,418

-4,425

-3,509

-4,530

-5,509

-4,780

-5,361

-2,884

-1,755

-908

-788

-115

41

-1,095

-1,014

-1,891

-2,498

-1,836

-1,602

-729

-265

186

0

0

0

Changes in assets and liabilities (net of acquisitions):
Accounts receivable

-11,586

6,989

11,635

10,403

6,362

8,223

10,295

8,886

9,536

-2,483

-7,789

-6,667

-6,594

1,118

6,056

10,311

11,355

13,078

7,207

3,195

3,447

11,100

7,499

5,648

3,977

1,084

1,321

559

8,573

2,188

674

1,300

-5,993

4,673

0

0

0

Inventories

42,566

32,866

33,531

40,277

37,352

35,887

34,054

30,494

32,648

29,526

24,735

13,781

7,336

187

-5,422

1,353

9,839

24,695

33,812

32,604

29,175

21,619

24,930

22,452

15,470

9,186

5,425

3,136

3,832

3,057

22,428

3,240

6,277

7,939

0

0

0

Prepaid expenses and other current assets

-11,525

-7,106

-5,140

-5,449

-23,392

-45,712

-6,252

2,048

5,289

22,744

-8,226

-29,861

-30,124

-22,441

-12,467

10,832

21,012

10,471

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

847

-15,866

-9,768

996

450

6,022

1,731

-1,040

4,599

6,260

16,414

12,620

4,617

1,495

-11,444

-12,532

-9,756

-2,919

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other liabilities

-21,444

-27,822

-24,600

-18,295

-2,247

14,839

24,396

29,204

15,815

21,834

19,912

25,615

24,992

-11,251

1,247

-10,702

9,597

23,258

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Metal-on-metal product liabilities

-23,023

-34,003

-44,146

-60,631

-87,855

-103,056

-138,596

-150,283

-117,704

-79,139

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) operating activities

68,359

41,607

-32,901

-56,463

-52,342

-63,729

-68,051

-179,157

-189,140

-184,810

-66,131

50,272

33,124

37,824

-79,384

-168,136

-180,402

-195,870

-136,314

-50,097

-27,605

1,008

2,144

7,346

11,931

24,982

21,616

18,856

22,010

14,431

23,341

24,017

25,053

23,166

0

0

0

Investing activities:
Additions of instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

83

19,598

2,504

2,895

2,935

2,086

3,704

1,120

1,410

0

0

0

-

-

-

-

Additions of instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25,890

25,726

23,805

19,319

32,220

12,956

11,999

13,937

3,507

20,782

19,734

0

0

0

Capital expenditures

98,339

99,286

85,396

89,742

85,029

71,467

63,918

61,851

63,211

63,474

61,775

56,693

53,169

50,099

47,453

42,673

40,891

43,666

36,379

31,368

20,584

10,494

11,435

10,927

9,760

10,825

10,543

18,373

11,564

9,891

9,693

1,419

7,041

6,599

0

0

0

Purchase of intangible assets

8,724

8,448

7,082

5,492

3,780

2,483

2,979

1,760

1,777

2,099

1,492

1,566

4,256

4,845

4,761

4,223

1,467

82

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accruals

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,489

11,323

10,042

6,234

7,421

3,827

5,215

4,199

87

2,593

980

5,584

2,573

0

0

0

Other current assets and liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,190

412

-3,418

-5,628

-4,704

-2,194

2,412

1,848

1,526

886

483

387

-3,987

0

0

0

Other non-current assets and liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,222

-725

1,766

4,031

2,134

911

-624

-1,590

-65

111

-597

130

194

0

0

0

Acquisition of business

0

-722

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,000

4,993

10,595

7,673

8,665

0

0

0

-

-

-

-

-

-

-

0

Other investing

-4,266

-3,766

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales and maturities of available-for-sale marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,566

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-102,797

-103,246

-523,779

-526,535

-524,876

-510,239

-111,245

-107,959

-108,836

-109,421

-42,564

-37,556

-36,722

-34,241

-22,097

-21,684

-17,146

-15,970

-41,865

-30,561

-33,131

-34,328

-43,286

-49,916

-46,054

-46,230

-136,849

-133,582

-131,107

-125,795

-29,395

-33,472

-30,834

-29,475

0

0

0

Financing activities:
Issuance of ordinary shares

45,309

52,076

26,264

29,919

29,980

21,618

13,698

13,594

15,542

27,551

27,634

27,356

22,344

8,460

6,083

2,416

4,204

3,513

4,216

3,780

3,827

3,976

4,342

14,162

19,164

21,481

20,585

10,970

7,179

7,710

0

0

0

-

-

-

-

Repayment of notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-116,108

0

0

0

Proceeds from long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

121,045

0

0

0

-

-

-

-

Deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

111

0

0

0

-

-

-

-

-

-

-

-

Payment of equity offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Issuance of stock warrants

0

21,210

21,210

21,210

123,347

102,137

102,137

102,137

0

0

0

0

0

-

-

-

-

87,072

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of notes premium

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of notes hedge options

0

30,144

30,144

30,144

171,422

141,278

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of long term borrowings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repurchase of stock warrants

0

11,026

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

59,803

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of equity issuance costs

0

350

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from notes hedge options

351

16,849

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

69,764

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from other debt

1,537

4,511

6,513

5,360

26,175

25,243

0

0

0

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in short-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,009

7,022

9,303

5,410

-10,513

0

0

0

Payments of debt

61,808

4,695

8,036

18,996

38,641

38,637

34,862

24,415

-9

11,517

0

0

0

-

-

-

-

-

-

-

-

-

-

1,329

52,090

54,095

74,139

85,964

29,021

28,684

9,922

181

8,119

8,147

0

0

0

Payment of financing costs

392

2,981

3,587

16,936

17,290

14,701

0

0

0

-

-

-

-

-

-

-

-

20,081

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repurchase of stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of contingent consideration

-

-

-

-

-

-919

-919

-1,361

-1,361

-1,429

-1,800

-2,022

-2,022

-1,035

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of finance lease obligations

7,918

7,837

7,477

6,853

5,913

5,508

4,732

4,184

3,596

2,690

2,555

2,464

2,663

2,514

1,913

1,338

768

621

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of ordinary shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

283

366

211

78,978

78,952

0

0

0

-

-

3,314

3,370

171,577

0

0

0

Excess tax benefit from stock-based compensation arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by financing activities

-23,274

37,406

9,886

420,772

601,894

598,140

596,802

220,355

47,537

46,816

71,767

40,706

269,688

270,417

161,107

88,559

-146,694

126,862

207,830

276,848

277,395

2,700

3,575

13,776

45,306

45,540

117,323

110,232

77,465

86,666

10,023

17,117

13,789

39,110

0

0

0

Effect of exchange rates on cash and cash equivalents

-967

-262

-846

-414

-1,211

-561

-392

1,080

2,508

2,890

403

-778

-1,512

-1,539

253

-353

397

-2,544

-532

518

-209

1,776

945

1,850

2,385

1,384

1,963

1,785

-1,590

1,100

-1,318

-5,971

-3,055

-2,933

0

0

0

Net decrease in cash and cash equivalents

-58,679

-24,495

-547,640

-162,640

23,465

23,611

417,114

-65,681

-247,931

-244,525

-36,525

52,644

264,578

272,461

59,879

-101,614

-343,845

-87,522

29,119

196,708

216,450

-28,844

-36,622

-26,944

13,568

25,676

4,053

-2,709

-33,222

-23,598

2,651

1,691

4,953

29,868

0

0

0

Supplemental disclosure:
Fixed assets acquired pursuant to capital lease

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

640

0

0

0